{"id":"https://openalex.org/W39209003","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e19689","title":"The role of an all-oral chemotherapy containing capecitabine and etoposide in advanced, progressive metastatic disease: A patient-friendly palliative option that can result in long-term disease control\u2014A study from India.","display_name":"The role of an all-oral chemotherapy containing capecitabine and etoposide in advanced, progressive metastatic disease: A patient-friendly palliative option that can result in long-term disease control\u2014A study from India.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W39209003","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e19689","mag":"39209003"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.e19689","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e19689","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.e19689","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043317951","display_name":"A. Chandra","orcid":"https://orcid.org/0000-0001-8699-965X","observed_orcids":["https://orcid.org/0000-0001-8699-965X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"A. Chandra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5043317951"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"e19689","last_page":"e19689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13340","display_name":"Palliative and Oncologic Care","score":0.4456000030040741,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13340","display_name":"Palliative and Oncologic Care","score":0.4456000030040741,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.1185000017285347,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.10520000010728836,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.8600000143051147},{"id":"https://openalex.org/keywords/palliative-chemotherapy","display_name":"palliative chemotherapy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.6069999933242798},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6039999723434448},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9639999866485596},{"id":"https://openalex.org/keywords/ascites","display_name":"ascites","score":0.7049999833106995},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.921999990940094},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5950000286102295},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8230000138282776},{"id":"https://openalex.org/keywords/resource-limited-settings","display_name":"resource-limited settings","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9459961652755737},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.6240183711051941},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6116599440574646},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.575469434261322},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.5281612277030945},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.47313109040260315},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.466930091381073},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.46606189012527466},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4263330101966858},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4216248393058777},{"id":"https://openalex.org/C2994186709","wikidata":"https://www.wikidata.org/wiki/Q29483","display_name":"Palliative care","level":2,"score":0.4131550192832947},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38903164863586426},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32970020174980164},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3221660256385803},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.28630876541137695},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.13617005944252014},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.e19689","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e19689","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.e19689","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2033753624","https://openalex.org/W2560225390","https://openalex.org/W1995311580","https://openalex.org/W2067744160","https://openalex.org/W2074177582","https://openalex.org/W2977721938","https://openalex.org/W1971172137","https://openalex.org/W1978157879","https://openalex.org/W2092696651","https://openalex.org/W2321492012"],"abstract_inverted_index":{"e19689":[0],"Background:":[1],"Chemotherapeutic":[2],"treatment":[3,72],"prolongs":[4],"survival":[5,106,118],"in":[6,10,27,47,148,162,171,204,219,234,254],"comparison":[7],"with":[8,12,29,39,57,68,126,155,256],"placebo":[9],"patients":[11,28,56,125,130,154,166,174,255],"advanced":[13,257],"progressive":[14,49,132],"metatstatic":[15],"cancer.":[16,258],"Nevertheless,":[17],"the":[18,115,123,152,165,195,226,246],"impact":[19],"of":[20,24,77,151,164,194,198,250],"chemotherapy":[21,215],"on":[22,95],"quality":[23],"life":[25],"and":[26,43,84,114,139,167,186,223,230,248],"poor":[30],"prognosis":[31],"is":[32],"unknown.":[33],"Current":[34],"chemotherapeutic":[35,252],"regimens":[36],"are":[37,241],"associated":[38],"significant":[40,260],"side":[41],"effects":[42],"only":[44],"limited":[45,235],"activity":[46],"metastatic":[48],"disease.":[50,143],"Methods:":[51],"The":[52,71,104,178],"subjects":[53],"were":[54,66,183,209],"50":[55,124],"severe":[58],"disseminated":[59,221],"cancer":[60,222],"(breast,":[61],"lung,":[62],"gastrointestinal,":[63],"etc.)":[64],"who":[65],"treated":[67],"oral":[69],"chemotherapy.":[70],"schedule":[73],"comprised":[74],"daily":[75],"administration":[76,197],"capecitabine":[78],"(1,000":[79],"mg)":[80,87],"for":[81,88],"2":[82,205],"weeks":[83],"etoposide":[85],"(50":[86],"21":[89],"days.":[90,97,121],"Next":[91],"cycle":[92],"was":[93,108,119,160,169],"administered":[94],"28":[96],"This":[98],"continued":[99],"until":[100],"disease":[101,202],"progression.":[102],"Results:":[103],"median":[105,116],"time":[107],"400":[109],"days,":[110],"(range":[111],"90-720":[112],"days)":[113],"progression-free":[117],"250":[120],"Of":[122],"measurable":[127],"lesions,":[128],"19%":[129],"had":[131,141,175],"disease,":[133],"41%":[134],"achieved":[135],"a":[136],"partial":[137],"response":[138],"40%":[140],"stable":[142],"Ascites":[144],"volume":[145],"decreased":[146],"markedly":[147],"14":[149],"(54%)":[150],"26":[153],"ascites.":[156],"Grade":[157],"3":[158,180],"neutropenia":[159],"observed":[161,170],"20%":[163],"anemia":[168],"45%.":[172],"4":[173],"febrile":[176],"neutropenia.":[177],"grade":[179],"nonhematological":[181],"toxicities":[182],"vomiting":[184],"(6%)":[185],"fatigue":[187],"(40%).":[188],"Early":[189],"death,":[190],"within":[191],"30":[192],"days":[193],"last":[196],"occurred":[199],"due":[200],"to":[201,243,263],"progression":[203],"patients,":[206],"but":[207],"there":[208],"1":[210],"treatment-related":[211],"deaths.":[212],"Conclusions:":[213],"Oral":[214],"may":[216],"be":[217],"effective":[218],"treating":[220],"might":[224],"improve":[225],"patient's":[227],"condition,":[228],"economic":[229],"patient":[231],"friendly":[232],"regime":[233],"resource":[236],"countries.":[237],"Well-designed,":[238],"controlled":[239],"trials":[240],"needed":[242],"further":[244],"evaluate":[245],"risks":[247],"benefits":[249],"different":[251],"schedules":[253],"No":[259],"financial":[261],"relationships":[262],"disclose.":[264]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2016-06-24T00:00:00"}